Archives
-
HBsAg–TBK1 Control of Interferon and Autophagy
2026-09-15
The 2025 Cell Death and Disease study identifies a mechanism by which hepatitis B surface antigen redirects TBK1 signaling away from IRF3-dependent type I interferon production and toward early, incomplete autophagy. Its combination of molecular interaction studies, TBK1 inhibition, animal models, and human liver tissue analysis links this signaling switch to HBV replication and persistent infection.
-
NADH as a Redox Control in Metabolic Research
2026-09-14
NADH is more than an electron carrier: it is an experimentally actionable variable linking mitochondrial respiration, diabetic nephropathy research, and redox-sensitive disease models. This guide translates NADH/NAD⁺ biology into assay design, handling, and interpretation decisions using evidence from a key diabetic kidney disease review.
-
Hypoxia-Primed hBMSCs Improve Liver Graft IRI
2026-09-14
Luo et al. show that hypoxia-preconditioned human bone marrow-derived mesenchymal stem cells improve mitochondrial quality and transfer more mitochondria to hepatocytes during hepatic ischemia-reperfusion injury. The study identifies connexin 43- and connexin 32-dependent gap-junction communication as an important regulatory interface, while also highlighting the need to distinguish gap-junction facilitation from direct mitochondrial passage through connexin pores.
-
Ivermectin: Causal Assay Design for Parasite Biology
2026-09-13
Ivermectin is a broad-spectrum anti-parasitic compound whose value depends on disciplined exposure, endpoint selection, and mechanistic interpretation. This guide uses insights from GSDMC research to show how parasite assays can distinguish phenotype, target engagement, and translational relevance without overextending oncology findings.
-
EZ Cap™ Firefly Luciferase mRNA for Imaging
2026-09-12
Turn nanoparticle delivery, translation, and cell-response questions into a quantitative luminescence workflow with a Cap1- and poly(A)-optimized reporter. This guide shows how to use EZ Cap™ Firefly Luciferase mRNA for cell assays, formulation comparisons, and longitudinal in vivo bioluminescence imaging while avoiding common interpretation and handling errors.
-
GRE Combination: Anti-Melanogenic Mechanisms
2026-09-11
Huang and colleagues evaluated glabridin, resveratrol, ellagic acid, and their combinations in cellular models of melanogenesis, oxidative stress, and inflammation. Their central finding was that the GRE combination most consistently suppressed melanin production, tyrosinase activity, CREB phosphorylation, MITF-associated responses, DPPH radicals, and LPS-induced nitric oxide production, while the study also highlights important limits of translating in vitro activity into treatment claims.
-
Spermine as a Probe of Membrane Excitability
2026-09-11
Spermine is an endogenous polyamine that links ion channel regulation with cell growth and protein synthesis. This article develops a measurement-first framework for using it in cellular metabolism research while distinguishing established channel pharmacology from emerging herpesvirus membrane-fusion biology.
-
TCAIM, OGDH, and Mitochondrial Metabolism
2026-09-10
The 2025 Molecular Cell study identifies TCAIM as a DNAJC co-chaperone that selectively binds native OGDH and lowers its protein abundance through HSPA9 and LONP1. This mechanism links mitochondrial proteostasis to control of OGDH complex activity, carbohydrate catabolism, and broader mitochondrial metabolic state.
-
E-4031: hERG Potassium Channel Blocker
2026-09-10
E-4031 is a potent hERG potassium channel blocker used in preclinical cardiac electrophysiology research. Its reported 7.7 nM IC50, effects on IKr-mediated repolarization, and ability to model QT interval prolongation and torsades de pointes (TdP) induction make it useful for controlled proarrhythmic substrate modeling.
-
LMO2–LDB1 Signaling in Acute Myeloid Leukemia
2026-09-09
The reference study identifies an LMO2/LDB1 protein complex as a functional driver of acute myeloid leukemia cell proliferation and survival. By combining gene perturbation, protein-interaction analysis, transcriptomics, chromatin profiling, and in vivo experiments, it positions LDB1 and LMO2 as a mechanistically connected axis for AML research.
-
Pexmetinib (ARRY-614): A Phosphatase-Aware View
2026-09-09
Pexmetinib (ARRY-614) is examined through a phosphatase-aware framework that connects dual p38 MAPK–Tie2 activity with cytokine assays and myelodysplastic syndromes research. The article explains how activation-loop biology can improve endpoint selection and interpretation without overstating what current evidence proves.
-
Berberine Hydrochloride Research Workflows
2026-09-08
Build reproducible Berberine hydrochloride workflows for gut–bone, metabolic, antimicrobial, and cell-death studies. This guide translates a new tuft-cell mechanism into practical dosing, controls, assay readouts, and troubleshooting decisions while separating evidence-backed findings from exploratory protocol choices.
-
Heparin Sodium for Coagulation and Nanovesicle Research
2026-09-08
Heparin sodium A5066 provides a reproducible anticoagulation benchmark for anti-factor Xa activity assays and activated partial thromboplastin time measurements. This guide also explains how to use it cautiously as an exploratory competition reagent when studying heparan sulfate proteoglycan-mediated nanovesicle uptake, without confusing anticoagulant activity with delivery mechanism.
-
Radioiodinated Balsalazide for Ulcerative Colitis
2026-09-07
The reference study developed and evaluated radioiodinated balsalazide as a murine ulcerative colitis imaging tracer, combining optimized labeling, stability testing, and comparative biodistribution. Its most important practical finding was substantial accumulation in ulcerated colon tissue, supporting further preclinical investigation while leaving questions about specificity, dosimetry, and translation unresolved.
-
740 Y-P PI 3-Kinase Activator Workflow
2026-09-07
740 Y-P provides a cell-permeable route to experimentally activate PI3K/AKT signaling in vesicular trafficking, cancer, and neuronal survival models. This guide combines pathway-aware assay design, handling advice, and troubleshooting with a practical interpretation of recent oxidative-stress research.